Results 71 to 80 of about 19,040 (169)

Heparin-induced thrombocytopenia after MitraClip: A case report

Türk Kardiyoloji Derneği Arşivi, 2018
Heparin-induced thrombocytopenia (HIT) and heparin-induced thrombocytopenia and thrombosis are potentially fatal adverse reactions to heparin therapy caused by the formation of polyclonal antibodies against the platelet factor 4-heparin complex.
Özge Çetinarslan, Ümit Yaşar Sinan, Emir Barış Ökçün, Cengiz Çeliker, Nuh Nazmi Gültekin   +4 more
doaj   +1 more source

Association of medical comorbidities in obese subjects diagnosed with heparin-induced thrombocytopenia

SAGE Open Medicine
Objectives: Heparin-induced thrombocytopenia can occur in obese subjects. The medical comorbidities associated with obesity may contribute to the pathogenesis of this disease.
Matthew Darok, Alexander Daly, Vonn Walter, Conrad Krawiec   +3 more
doaj   +1 more source

THE THE HEPARIN INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS

Pakistan Armed Forces Medical Journal, 2020
Objective: Combination of ‘4Ts’ clinical scoring system and Particle gel immunoassay to determine the frequency of heparin-induced thrombocytopenia during heparin treatment in cardiac surgery patients. Study Design: Prospective observational study.
Shakila Khadim, Nuzhat Salamat, Saleem Ahmad Khan, Kifayatullah ., Nisaruddin ., Muhammad Abdul Naeem   +5 more
doaj  

Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients

Haematologica, 2012
Background The current gold-standard for diagnosing heparin-induced thrombocytopenia is the detection of platelet-activating antibodies by means of functional assays which, since they are time consuming and not widely available, are not suited to guiding
Vanessa Nellen, Irmela Sulzer, Gabriela Barizzi, Bernhard Lämmle, Lorenzo Alberio   +4 more
doaj   +1 more source

Giant cellulitis‐like Sweet's syndrome induced by gilteritinib

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 10, Page e1472-e1474, October 2026.
Juan de Luque‐Fernández, Irene Rivera‐Ruiz, Irene Suárez‐Vergne, Inmaculada Sánchez‐Ramírez, Manuel Galán‐Gutiérrez, Antonio José Vélez García‐Nieto   +5 more
wiley   +1 more source

Management of Heparin-Induced Thrombocytopenia with Fondaparinux in a Patient with Left Ventricular Assist Device

International Journal of Organ Transplantation Medicine, 2014
Heparin-induced thrombocytopenia is an immune-mediated serious adverse effect of heparin therapy. It is a relatively frequent complication among patients with mechanical circulatory support.
V Velagic, J Samardzic, Z Baricevic, B Skoric, M Cikes, H Gasparovic, B Biocina, D Milicic   +7 more
doaj  

Refractory Heparin-Induced Thrombocytopenia With Cerebral Venous Sinus Thrombosis Treated With IVIg, Steroids, and a Combination of Anticoagulants: A Case Report

Journal of Investigative Medicine High Impact Case Reports, 2019
Heparin-induced thrombocytopenia (HIT) type II is caused by antibody production that bind complexes between heparin and platelet factor 4 leading to platelet consumption and thrombosis.
Mia Gonzales MD, MPH, Amrish Pipalia MD, Andrew Weil MD   +2 more
doaj   +1 more source

Hats Off to HIT: A Case Report

Oman Medical Journal, 2012
Thrombocytopenia is a well- recognized complication of heparin therapy. The diagnosis is mostly clinical and the main value of laboratory testing is in excluding the diagnosis.
Akhwand Shakeel Ahmad, Dhia Jaber Al-Layla, Manjula Dhinakar   +2 more
doaj  

Dabigatran, a direct thrombin inhibitor, can be a life-saving treatment in heparin-induced thrombocytopenia

ARYA Atherosclerosis, 2013
BACKGROUND: Several studies have emphasized thrombosis associated with thrombocytopenia as a potentially fatal complication of heparin. A number of agents are used for this condition.
Ahmad Mirdamadi
doaj  

Low-molecular-weight heparin-induced thrombocytopenia with multisite embolism: successful management with argatroban and dabigatran – a case report and literature review

Frontiers in Pharmacology
Heparin-induced thrombocytopenia (HIT) is a rare but potentially life-threatening complication, with an incidence ranging from approximately 0.2%–5.0%.
Huixin Zhao, Xiaowan Tang, Xitao Song
doaj   +1 more source